Millipore and Novo Nordisk Expand Agreement to Supply Biopharmaceutical Market with Recombinant Human Insulin
Millipore gains long-term exclusive worldwide rights to distribute Novo Nordisk's insulin for cell culture applications
17-Aug-2007 -
Millipore Corporation announced an expansion of its agreement with Novo Nordisk to provide the biopharmaceutical market with recombinant human insulin, a key cell culture supplement used to manufacture biologic drugs.
Under the terms of the agreement, Millipore will have exclusive worldwide ...
cell culture media
cell cultures
cell lines
+2